![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
EMD Serono, ICR and Wellcome Trust partner develop anti-cancer drugs
Merck subsidiary EMD Serono, The Institute of Cancer Research (ICR) and the Wellcome Trust...
Novartis and BMS enter clinical collaboration to assess lung cancer treatments
Swiss drug maker Novartis has partnered with US-based Bristol-Myers Squibb (BMS) to assess the...
UK’s Medical Research Council grants fund for three new research programmes
The UK Medical Research Council (MRC) has granted a fund of £6m for three new...
Afatinib drug could inhibit growth of womb cancer, say Yale scientists
Research conducted by scientists from the Yale School of Medicine gynaecologic oncology division...
PANEL: FLU SPRAY BETTER THAN SHOTS FOR YOUNG KIDS
When it comes to flu vaccines, a federal panel says a squirt in the nose...
Reducing readmissions: Top strategy for improving quality, lowering costs
Dr. Fortuna says payers should consider expand their perspectives on improving the healthcare system by...
Recycled blood is better than donated blood for transfusions, Hopkins study finds
We recycle a lot of things — paper, plastic, metal, blood. Yes, blood. During some...
Capravirine – Anti-Retroviral Drug
Developed by Pfizer Global Research and Development, capravirine is a Non-Nuclesoide Reverse Transcriptase Inhibitor (NNRTI)...
Abraxane for the Treatment of Late-Stage Pancreatic Cancer, United States of America
Abraxane (albumin-bound paclitaxel for injectable suspension) is an intravenous injection indicated for the treatment of...
Cetilistat – Investigational Drug for Obesity, Japan
Developed by Alizyme, a specialist biopharmaceutical company in collaboration with Takeda Pharmaceutical, cetilistat (ATL-962) is...